SEC Form 4 · accession 0001209191-15-023558
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Earl R Lewis
Director
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2015 | M | 47,414 | $4.04 | A | 312,408 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2,F3 | $4.04 | Mar 4, 2015 | M | 47,414 | D | — | Jun 2, 2021 | Common stock, par value $0.01 per share | 47,414 | 0 | D |
Explanation of responses
- F1Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 289,320 shares of common stock held by the Reporting Person.
- F2Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.
- F3The options vested in three equal installments on June 2, 2012, 2013 and 2014.
Remarks
This form is signed under power of attorney.